Answers are grounded in this paper and cite their sources.
Compares T-cell activation through CD3/CD28 and PMA/Ionomycin, highlighting key differences in signaling pathways.
PMA/ionomycin and CD3/CD28 stimulation induce fundamentally distinct signaling programs in primary human T cells. While CD3/CD28 stimulation activates both ERK and IL-2/STAT5 signaling pathways, PMA/ionomycin induces predominantly ERK-dependent proliferation despite robust IL-2 production and CD25 upregulation. These findings highlight important mechanistic and methodological differences between pharmacological and receptor-mediated T-cell activation.
No takes yet. Share an insight, caveat, or question.
Abdulhaqov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: